CorneaGen
  • SURGEON PORTAL
  • Contact Us
  • CORNEAL TISSUE
    • Tissue Overview
    • Tissue Services
      • DSAEK
      • DMEK
      • Geuder Pre-Loaded Glass Cannula
      • Ampho B
      • PKP
      • ALK
      • FLAK
      • VisionGraft
      • Sclera
    • Reimbursement Assistance
    • Adverse Reaction Reporting
    • Regulatory Information
    • Request Tissue
  • Products
    • Products Overview
    • Corneal Products
      • EndoSerter-PL
      • EndoSerter
      • Cannula
      • Geuder Pre-Loaded Glass Cannula
      • Donor Punch
      • Recipient Trephine
      • Intacs
  • Innovation
  • Education
    • Educational Videos
    • Wet Labs
    • Fellows Program
  • About Us
    • Our People
    • Our Partners
    • Gift of Sight
    • Core Commitments
    • Careers
    • Our Locations
    • News & Events
Request Tissue Contact Us
Jane Rady

Jane Rady

December 9, 2022

Jane E. Rady serves as senior vice president, corporate strategy and business development at Glaukos. From 2017 to April 2018, she was vice president, business development for Johnson & Johnson Surgical Vision, following the 2017 acquisition by Johnson & Johnson of Abbott Medical Optics, a division of Abbott Laboratories. From 2009 to 2017, she was divisional vice president, business development for Abbott Medical Optics. From 2002 to 2009, she held several executive leadership positions at Advanced Medical Optics, Inc. (AMO), which was acquired by Abbott Laboratories in 2009. While at AMO, Ms. Rady headed various functions, including business development, strategic planning, research and development, clinical development, regulatory affairs and government affairs. Her prior experiences includes positions at Monsanto Corporation, G.D. Searle and Abbott Laboratories. Ms. Rady holds a B.S. in biology and a M.S. in molecular biology/microbiology from the University of Illinois and an M.B.A. from the Kellogg Graduate School of Management at Northwestern University.

Recent Articles

  • Bernie’s Quarterly Update – December 2022

    Bernie’s Quarterly Update – December 2022

    As we near the end of a very strong quarter...

    READ MORE
  • Bernie’s Quarterly Update – September 2022

    Bernie’s Quarterly Update – September 2022

    We approach the end of another great quarter and exciting...

    READ MORE
  • Bernie’s Quarterly Update – June 2022

    Bernie’s Quarterly Update – June 2022

    It has been just over a year since I officially...

    READ MORE
  • CorneaGen Advances Next Generation of DSEK Surgery Innovation

    CorneaGen Advances Next Generation of DSEK Surgery Innovation

    New FDA approved, pre-loaded cornea graft insertion device maximizes efficiency...

    READ MORE
Navigation
  • Corneal Tissue
  • Products
  • Innovation
  • Education
  • About Us
  • Request Tissue
Helpful Information
  • Reimbursement assistance
  • Adverse reaction reporting
  • KAMRA Support
  • Careers
Legal
  • Privacy Policy
  • Terms and conditions
  • Regulatory Information
Connect
  • Contact Us
CorneaGen

©2023 CorneaGen

CorneaGen